Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice.

[1]  Xiang Li,et al.  Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation. , 2020, International immunopharmacology.

[2]  Xiang Li,et al.  SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation , 2020, Respiratory Research.

[3]  H. Pape,et al.  Mortality of Adult Respiratory Distress Syndrome in Trauma Patients: A Systematic Review over a Period of Four Decades , 2020, World Journal of Surgery.

[4]  K. Hibbert,et al.  Recent advances in the understanding and management of ARDS , 2019, F1000Research.

[5]  Jian Liu,et al.  Triptolide protects against TGF-β1-induced pulmonary fibrosis by regulating FAK/calpain signaling , 2019, Experimental and therapeutic medicine.

[6]  Yahui Wang,et al.  Abstract. Aim: Hypercoagulation and fibrinolysis inhibition in the alveolar cavity are important characteristics in acute respiratory distress syndrome (ARDS). Alveolar epithelial cells type II (AEC II) have been confirmed to have significant role in regulating alveolar hypercoagulation and fibrinol , 2019 .

[7]  Xi Chen,et al.  The Roles of Plant-Derived Triptolide on Non-Small Cell Lung Cancer , 2019, Oncology research.

[8]  Xiujing Feng,et al.  Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats. , 2019, International immunopharmacology.

[9]  Liming Chen,et al.  Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease , 2018, International journal of biological sciences.

[10]  A. Xu,et al.  Triptolide inhibits the inflammatory activities of neutrophils to ameliorate chronic arthritis , 2018, Molecular immunology.

[11]  Karen E. Williams,et al.  Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries , 2018, Critical Care.

[12]  Xiaotian Sun,et al.  Triptolide: A new star for treating human malignancies , 2018, Journal of cancer research and therapeutics.

[13]  Yahui Wang,et al.  NF-κB p65 Knock-down inhibits TF, PAI-1 and promotes activated protein C production in lipopolysaccharide-stimulated alveolar epithelial cells type II , 2018, Experimental lung research.

[14]  W. Kuebler,et al.  Difficulties in modelling ARDS (2017 Grover Conference Series) , 2018, Pulmonary circulation.

[15]  Bin Yang,et al.  Triptolide reduces ischemia/reperfusion injury in rats and H9C2 cells via inhibition of NF-κB, ROS and the ERK1/2 pathway , 2018, International journal of molecular medicine.

[16]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[17]  A. Artigas,et al.  Anticoagulant therapy in acute respiratory distress syndrome. , 2018, Annals of translational medicine.

[18]  P. Okunieff,et al.  Triptolide mitigates radiation-induced pneumonitis via inhibition of alveolar macrophages and related inflammatory molecules , 2017, Oncotarget.

[19]  Y. Ye,et al.  Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway. , 2016, International immunopharmacology.

[20]  Jianhua Huang,et al.  NEMO-Binding Domain Peptide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting the NF-κB Signaling Pathway , 2016, Mediators of inflammation.

[21]  Y. Cho,et al.  Clinical Practice Guideline of Acute Respiratory Distress Syndrome , 2016, Tuberculosis and respiratory diseases.

[22]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[23]  D. Raz,et al.  Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis. , 2015, The Annals of thoracic surgery.

[24]  R. Lucas,et al.  The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches. , 2015, Austin journal of vascular medicine.

[25]  M. May,et al.  NEMO-binding domain peptide inhibition of inflammatory signal-induced NF-κB activation in vivo. , 2015, Methods in molecular biology.

[26]  Xian Wang,et al.  Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model. , 2014, Molecular Medicine Reports.

[27]  S. Ghosh,et al.  Regulation of NF-κB by TNF family cytokines. , 2014, Seminars in immunology.

[28]  J. Bastarache,et al.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome. , 2011, Current pharmaceutical biotechnology.

[29]  J. Chen,et al.  Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[30]  L. Nelin,et al.  Triptolide induces anti-inflammatory cellular responses. , 2009, American journal of translational research.

[31]  M. Karin.  How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.